Advertisement. Remove ads.
Monte Rosa Therapeutics Inc. ($GLUE)
Shares of Monte Rosa Therapeutics surged over 130% on Monday, reaching a two-year high of $12.15 after announcing an exclusive global licensing agreement with Novartis AG ($NVS).
The collaboration focuses on developing innovative treatments for immune-related conditions, particularly MRT-6160, an oral drug designed to inhibit the degradation of VAV1, a key signaling protein for T and B cell receptors.
As part of the agreement, Novartis will pay $150 million upfront for exclusive worldwide rights to MRT-6160 and other VAV1-targeting molecular glues, with Monte Rosa eligible for up to $2.1 billion in milestones and tiered royalties on international sales.
Retail sentiment on Stocktwits surged to ‘extremely bullish’ (97/100) with ‘extremely high’ (97/100) message volume.
Evoke Pharma Inc. ($EVOK)
Evoke Pharma’s shares were up over 30% on Monday following its presentation of positive data for its lead drug, Gimoti, as a treatment option for diabetes gastroparesis.
The company ranked among the top 10 trending stocks on Stocktwits, secured the second spot for most watched, and was listed in the top 20 most active stocks on Monday afternoon.
Evoke Pharma and its partner, Eversana, found that patients using Gimoti, a nasal version of metoclopramide, experienced significant improvements compared to those using the oral formulation. Patients who received the nasal treatment had reduced healthcare resource use and fewer healthcare visits.
Retail sentiment on Stocktwits surged into ‘extremely bullish’ territory (97/100) with ‘extremely high’ (97/100) message volume.
Autonomix Medical Inc. ($AMIX)
Shares of Autonomix skyrocketed by more than 90% on Monday morning following the announcement of positive results from its clinical trial aimed at alleviating pain in pancreatic cancer patients.
The stock became the second-highest trending on Stocktwits, just behind Trump Media & Technology Group Corp. ($DJT), and was listed among the top 10 most watched stocks of the day.
Retail sentiment on Stocktwits surged to ‘extremely bullish’ (97/100) with chatter escalating into ‘extremely high’ (97/100) territory.
For updates and corrections email newsroom@stocktwits.com.
Read more: MicroStrategy’s Bitcoin Holdings Drive Historic High: Retail Unfazed